What is OutcomesAI?
OutcomesAI operates at the intersection of clinical medicine and artificial intelligence, developing the Glia platform to optimize patient-navigation workflows. By pairing AI-driven voice agents with licensed nursing professionals, the company addresses the critical need for scalable clinical capacity. The platform is built upon a foundation of trusted clinical data and multimodal models, ensuring that all automated triage and documentation processes remain evidence-based and secure. With full HIPAA and SOC 2 certification, OutcomesAI provides a robust framework for healthcare providers to reduce the administrative burden on nursing staff while maintaining high standards of patient safety and data integrity.
How much funding has OutcomesAI raised?
OutcomesAI has raised a total of $10M across 1 funding round:
Seed
$10M
Seed (2025): $10M with participation from Santé Ventures
Key Investors in OutcomesAI
Santé Ventures
Santé Ventures is a specialized investment firm managing over $1 billion in capital, with a primary focus on the Biotech, Medtech, and Healthtech sectors. They are known for supporting visionary entrepreneurs who aim to enhance patient health outcomes through innovative technology.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for OutcomesAI?
With the recent capital infusion, OutcomesAI is expected to scale its engineering and clinical operations to meet increasing demand for automated healthcare solutions. The company will likely focus on expanding the capabilities of its voice agents and deepening the integration of its multimodal models within hospital systems. As the healthcare industry continues to grapple with staffing shortages and rising operational costs, OutcomesAI is well-positioned to capture significant market share by offering a scalable, technology-first approach to clinical triage. Future growth will likely involve strategic partnerships with large-scale health systems to further validate the efficacy of the Glia platform in diverse clinical settings.
See full OutcomesAI company page
